Search Tag: kidney infections

Pharmacy Management

2015 01 Mar

The FDA has approved the combination of ceftazidime-avibactam (CAZ-AVI). The antibiotic under the brand name of Avycaz will be marketed by Forest Laboratories and is indicated to treat adults with complicated intra-abdominal or urinary tract infections, including kidney infections. Ceftazidime is a third generation of cephalosporin that was approved...Read more